Immediate Impact
1 by Nobel laureates 1 from Science/Nature 66 standout
Citing Papers
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
Works of Bendik Lund being referenced
Pneumocystis jirovecipneumonia prophylaxis during maintenance therapy influences methotrexate/6‐mercaptopurine dosing but not event‐free survival for childhood acute lymphoblastic leukemia
2011
Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule.
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bendik Lund | 364 | 317 | 135 | 29 | 634 | |
| Peter H. Shaw | 168 | 278 | 103 | 35 | 601 | |
| Wing H. Tong | 273 | 233 | 92 | 27 | 629 | |
| Margarita Baka | 341 | 330 | 65 | 47 | 666 | |
| Kaie Pruunsild | 486 | 383 | 210 | 14 | 654 | |
| Kathrine Grell | 362 | 314 | 98 | 35 | 580 | |
| Ólafur Gísli Jónsson | 461 | 363 | 217 | 38 | 694 | |
| Peder Skov Wehner | 202 | 277 | 78 | 47 | 596 | |
| M.L. te Winkel | 317 | 379 | 154 | 25 | 739 | |
| Julian Katz | 250 | 210 | 81 | 19 | 580 | |
| Francisco Pedrosa | 371 | 320 | 124 | 31 | 642 |
All Works
Loading papers...